Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Reiner

Showing results (351-360 of 381) with videos related to

Pageof 39
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2018
Breast Cancer Family History and Contralateral Breast Cancer Risk in Young Women: An Update From the Women's Environmental Cancer and Radiation Epidemiology StudyAnne S Reiner, Julia Sisti, Esther M John, et al.
Neuro-Oncology|August 22, 2025
Multicenter basket trial for Central Nervous System tumors identifies activity of the CDK4/6 inhibitor abemaciclib in recurrent meningiomaThomas J Kaley, Christian Grommes, Elizabeth Coffee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 28, 2012
Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women's Environmental Cancer and Radiation Epidemiology StudyAnne S Reiner, Esther M John, Jennifer D Brooks, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2013
Tumor-infiltrating lymphocyte grade in primary melanomas is independently associated with melanoma-specific survival in the population-based genes, environment and melanoma studyNancy E Thomas, Klaus J Busam, Lynn From, et al.
European Journal of Cancer (Oxford, England : 1990)|May 28, 2013
Contralateral breast cancer after radiotherapy among BRCA1 and BRCA2 mutation carriers: a WECARE study reportJonine L Bernstein, Duncan C Thomas, Roy E Shore, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 30, 2014
Sun exposure and melanoma survival: a GEM studyMarianne Berwick, Anne S Reiner, Susan Paine, et al.
JACC. Cardiooncology|October 4, 2021
Coronary Artery Disease in Young Women After Radiation Therapy for Breast Cancer: The WECARE StudyLauren E Carlson, Gordon P Watt, Emily S Tonorezos, et al.
Journal of the National Cancer Institute|March 23, 2010
Radiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology studyJonine L Bernstein, Robert W Haile, Marilyn Stovall, et al.
Journal of the National Cancer Institute|March 3, 2020
Radiation Treatment, ATM, BRCA1/2, and CHEK2*1100delC Pathogenic Variants and Risk of Contralateral Breast CancerAnne S Reiner, Mark E Robson, Lene Mellemkjær, et al.
Neuro-Oncology|April 24, 2025
Phase Ib study with expansion of ibrutinib, lenalidomide and rituximab in patients with relapsed/refractory CNS lymphomaLauren R Schaff, Anna F Piotrowski, Elena Pentsova, et al.
Pageof 39

Showing results (351-360 of 381) with videos related to

Sort By:
Pageof 39
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2018
Breast Cancer Family History and Contralateral Breast Cancer Risk in Young Women: An Update From the Women's Environmental Cancer and Radiation Epidemiology StudyAnne S Reiner, Julia Sisti, Esther M John, et al.
Neuro-Oncology|August 22, 2025
Multicenter basket trial for Central Nervous System tumors identifies activity of the CDK4/6 inhibitor abemaciclib in recurrent meningiomaThomas J Kaley, Christian Grommes, Elizabeth Coffee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 28, 2012
Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women's Environmental Cancer and Radiation Epidemiology StudyAnne S Reiner, Esther M John, Jennifer D Brooks, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2013
Tumor-infiltrating lymphocyte grade in primary melanomas is independently associated with melanoma-specific survival in the population-based genes, environment and melanoma studyNancy E Thomas, Klaus J Busam, Lynn From, et al.
European Journal of Cancer (Oxford, England : 1990)|May 28, 2013
Contralateral breast cancer after radiotherapy among BRCA1 and BRCA2 mutation carriers: a WECARE study reportJonine L Bernstein, Duncan C Thomas, Roy E Shore, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 30, 2014
Sun exposure and melanoma survival: a GEM studyMarianne Berwick, Anne S Reiner, Susan Paine, et al.
JACC. Cardiooncology|October 4, 2021
Coronary Artery Disease in Young Women After Radiation Therapy for Breast Cancer: The WECARE StudyLauren E Carlson, Gordon P Watt, Emily S Tonorezos, et al.
Journal of the National Cancer Institute|March 23, 2010
Radiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology studyJonine L Bernstein, Robert W Haile, Marilyn Stovall, et al.
Journal of the National Cancer Institute|March 3, 2020
Radiation Treatment, ATM, BRCA1/2, and CHEK2*1100delC Pathogenic Variants and Risk of Contralateral Breast CancerAnne S Reiner, Mark E Robson, Lene Mellemkjær, et al.
Neuro-Oncology|April 24, 2025
Phase Ib study with expansion of ibrutinib, lenalidomide and rituximab in patients with relapsed/refractory CNS lymphomaLauren R Schaff, Anna F Piotrowski, Elena Pentsova, et al.
Pageof 39